Division of Reproductive Endocrinology and Infertility, Department of Obstetrics/Gynecology, Cedars-Sinai Medical Center, Los Angeles, California 90048 , USA.
Fertil Steril. 2010 Jun;94(1):353-6. doi: 10.1016/j.fertnstert.2009.09.050. Epub 2009 Nov 14.
FOXL2 is expressed in granulosa cells (GC) of small and medium ovarian follicles, functions as a repressor of the human steroidogenic acute regulatory gene, a marker of a GC differentiation, and its mutation is associated with premature ovarian failure (POF) in women with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES), type I. We now report that FOXL2 also represses the transcription of aromatase, P450scc, and cyclin D2, three other key genes involved in GC proliferation, differentiation, and steroidogenesis, and that a FOXL2 mutation found in patients with BPES type I, also fails to repress aromatase transcription, further supporting a role for FOXL2 in follicle maturation.
FOXL2 在小和中型卵巢卵泡的颗粒细胞 (GC) 中表达,作为人类类固醇生成急性调节基因的抑制剂,是 GC 分化的标志物,其突变与患有眼睑下垂-上睑下垂-内眦赘皮综合征 (BPES),I 型的女性的卵巢早衰 (POF) 有关。我们现在报告说,FOXL2 还抑制细胞色素 P450scc 和细胞周期蛋白 D2 的转录,这是另外三个参与 GC 增殖、分化和类固醇生成的关键基因,在 I 型 BPES 患者中发现的 FOXL2 突变也不能抑制芳香酶转录,进一步支持 FOXL2 在卵泡成熟中的作用。